Therapeutic Angiogenesis With Recombinant Fibroblast Growth Factor-2 Improves Stress and Rest Myocardial Perfusion Abnormalities in Patients With Severe Symptomatic Chronic Coronary Artery Disease
James E. Udelson(Tufts Medical Center), Michael Simons(Yale University), Vasken Dilsizian(University of Maryland, Baltimore), Carl Yoshizawa(Einstein Medical Center Philadelphia), Roger J. Laham(Beth Israel Deaconess Medical Center), Michel Blais(Tufts University), James R. Galt(Emory University), Marilyn C. Pike(Bethesda Hospital), Nicolas Chronos(Sanofi (France)), John Vansant(Tufts University)
Cited by 163
Related Papers
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
|Circulation|2011|2.1k
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
|Journal of the American College of Cardiology|2011|1.3k
Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy
|Circulation|2014|1k